BioSpace News Archive

MEI Pharma, Inc. announced the publication of data abstracts related to two of MEI Pharma’s clinical stage drug development programs to be presented at the 2019 ASCO Annual Meeting to be held May 31 to June 4, 2019 in Chicago.

Endo International plc announced that members of management will participate in a fireside chat at the RBC Annual Healthcare Conference in New York City on Tuesday, May 21, 2019 at 10:00 a.m. ET.

Ogivri™ is the first biosimilar for Herceptin® approved by the U.S. Food and Drug Administration (FDA) for all indications including HER2-positive breast and gastric cancers [15-May-2019] HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India , May 15, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced

AVEO Oncology announced two poster presentations at the upcoming American Society of Clinical Oncology Annual Meeting being held May 31-June 4, 2019 in Chicago, Illinois.

First developed in 2012, Altogen’s liver-targeted in vivo transfection reagent has since been successfully used in over 25 research publications for liver tissue and tumor-specific delivery of therapeutic biomolecules such as siRNA, miRNA, mRNA, plasmid DNA, and small proteins.

Amgen announced that data from its oncology pipeline will be presented at the 55th Annual Meeting of the American Society of Clinical Oncology in Chicago, May 31-June 4, 2019.

Rakuten Medical, a clinical-stage biotechnology company developing precision-targeted cancer therapies based on its proprietary photoimmunotherapy platform, will be presenting data from its Phase 2a clinical trial focused on RM-1929 PIT in patients with locoregional, recurrent head and neck squamous cell carcinoma during the ASCO annual meeting, May 31 – June 4, 2019 in Chicago.

Longas Technologies Pty Ltd (‘Longas’), a developer of Next Generation Sequencing (NGS) technologies, today emerges from stealth mode, unveiling its Morphoseq™ technology and announcing the appointment to CEO of Nick McCooke, who built and led the team at Solexa that pioneered NGS prior to the company being acquired by Illumina.

Aeneas Capital Limited and Pyrinas Real Estate Management Limited, based in Hong Kong, is launching a US$120m innovative closed-ended property fund – Pyrinas US Healthcare Real Estate Fund 1 SP – with a geographical focus on selected cities across North America.

AVITA Medical announced that the health economic model of the U.S. burn care pathway, developed in collaboration with Biomedical Advanced Research and Development Authority (BARDA) and IQVIA, has been published in the peer-reviewed journal, Advances in Therapy.